Inventaire - dine venner og fællesskaber er dit bedste bibliotek

Blood counts at time of complete remission provide additional independent prognostic information in acute myeloid leukemia

forfatter

Hagop Kantarjian

1952 -

Stefan Faderl

Farhad Ravandi

Gautam Borthakur

Sherry Pierce

Guillermo Garcia-Manero

Elihu Estey

Masamitsu Yanada

udgivet i: Leukemia Research

dato for udgivelse: 2008-04-10

main subject: leukæmi, akut myeloid leukæmi

Cites articles 17

Date

Titel

Forfattere

2007-03-22

The quality of molecular response to chemotherapy is predictive for the outcome of AML1-ETO-positive AML and is independent of pretreatment risk factors
2006-11-01

Acute myeloid leukaemia

Hartmut Döhner, Elihu Estey
2006-06-01

Quantitative assessment of minimal residual disease in acute myeloid leukemia carrying nucleophosmin (NPM1) gene mutations

Giorgina Specchia, Giuseppe Saglio, Brunangelo Falini
2005-05-03

Drug therapy for acute myeloid leukemia

Martin S. Tallman
2005-01-20

Cytoplasmic nucleophosmin in acute myelogenous leukemia with a normal karyotype

Laura Pasqualucci, Myriam Alcalay, Marco Vignetti, Brunangelo Falini, Giuseppe Saglio, Francesco Lo-Coco, Valentina Pettirossi
2004-07-29

Determination of relapse risk based on assessment of minimal residual disease during complete remission by multiparameter flow cytometry in unselected patients with acute myeloid leukemia

Claudia Schoch, Torsten Haferlach, Susanne Schnittger
2004-06-01

FLT3 mutation and response to intensive chemotherapy in young adult and elderly patients with normal karyotype.

Hagop Kantarjian, Elihu Estey
2004-06-01

Abnormal cytogenetics at date of morphologic complete remission predicts short overall and disease-free survival, and higher relapse rate in adult acute myeloid leukemia: results from cancer and leukemia group B study 8461

Kellie J Archer, Richard A. Larson, Nyla A Heerema, Clara D. Bloomfield, Krzysztof Mrózek
2003-12-01

Prognostic value of minimal residual disease quantification by real-time reverse transcriptase polymerase chain reaction in patients with core binding factor leukemias

Hartmut Döhner
2003-07-01

Independent prognostic significance of day 21 cytogenetic findings in newly-diagnosed acute myeloid leukemia or refractory anemia with excess blasts

Elihu Estey
2002-06-28

Early blast clearance by remission induction therapy is a major independent prognostic factor for both achievement of complete remission and long-term outcome in acute myeloid leukemia: data from the German AML Cooperative Group (AMLCG) 1992 Trial

Claudia Schoch, Torsten Haferlach, Wolfgang Hiddemann
2002-10-01

Favorable prognostic significance of CEBPA mutations in patients with de novo acute myeloid leukemia: a study from the Acute Leukemia French Association (ALFA)

Claude Preudhomme, Stéphane de Botton, Pierre Fenaux, Emmanuel Raffoux, Nicolas Boissel, Isabelle Tigaud, Sylvie Castaigne, Christophe Sagot, Charlotte Lamandin
2001-12-01

Comparison of idarubicin + ara-C-, fludarabine + ara-C-, and topotecan + ara-C-based regimens in treatment of newly diagnosed acute myeloid leukemia, refractory anemia with excess blasts in transformation, or refractory anemia with excess blasts
2001-09-01

Early immunophenotypical evaluation of minimal residual disease in acute myeloid leukemia identifies different patient risk groups and may contribute to postinduction treatment stratification

Jesús San Miguel, María-Belén Vidriales, Norma C. Gutiérrez, Marcos González Díaz, Alberto Orfao
2000-01-01

Effect of time to complete remission on subsequent survival and disease-free survival time in AML, RAEB-t, and RAEB
1999-10

A simple, robust, validated and highly predictive index for the determination of risk-directed therapy in acute myeloid leukaemia derived from the MRC AML 10 trial. United Kingdom Medical Research Council's Adult and Childhood Leukaemia Working Parties

Anthony H. Goldstone
1980-04-01

Factors related to length of complete remission in adult acute leukemia

Artikel - wd:Q34279037

Welcome to Inventaire

dit venne- og fællesskabs bibliotek

vil du vide mere